Disposable Pressure Transducers Market Global Report 2026

The disposable pressure transducers market size has grown rapidly in recent years. It will grow from $6.1 billion in 2025 to $6.78 billion in 2026 at a compound annual growth rate (CAGR) of 11.1%. The growth during the historic period was driven by increasing prevalence of cardiovascular and critical care conditions, growing demand for infection prevention in healthcare facilities, rising adoption of invasive blood pressure monitoring procedures, expansion of intensive care unit infrastructure, and increasing preference for disposable medical devices.

The disposable pressure transducers market size is expected to see rapid growth in the next few years. It will grow to $10.19 billion in 2030 at a compound annual growth rate (CAGR) of 10.7%. The growth during the forecast period is attributed to growing integration of smart monitoring capabilities in pressure transducers, rising demand for advanced hemodynamic monitoring solutions, increasing adoption of wireless and digital pressure monitoring systems, expanding critical care facilities in emerging regions, and growing focus on reducing healthcare-associated infections. Major trends in the forecast period include increasing adoption of single-use pressure monitoring devices, growing demand for infection control in critical care environments, rising focus on accurate real-time hemodynamic monitoring, increasing development of advanced disposable sensor technologies, and growing preference for minimally invasive patient monitoring solutions.

The rising prevalence of cardiovascular diseases is expected to propel the growth of the disposable pressure transducers market. Cardiovascular diseases (CVDs) refer to a group of disorders affecting the heart and blood vessels, including conditions such as coronary artery disease, stroke, heart failure, and hypertension. The growing prevalence of cardiovascular diseases is mainly attributed to unhealthy lifestyles, which adversely impact heart health and increase the likelihood of developing heart-related conditions. Disposable pressure transducers support the management of cardiovascular diseases by providing accurate, real-time invasive blood pressure monitoring, enabling precise diagnosis, continuous hemodynamic assessment, and timely clinical decision-making in critical cardiac care settings. For instance, in March 2025, according to the Joint Strategic Needs Assessment, a UK-based community health center, the number of deaths caused by cardiovascular disease (CVD) reached 185 in 2023, compared to 178 reported in 2022. Therefore, the increasing prevalence of cardiovascular diseases is driving the growth of the disposable pressure transducers market.

Major companies operating in the disposable pressure transducers market are focusing on developing innovative solutions that advance precision in patient monitoring to improve clinical accuracy, enhance patient safety, and support real-time decision-making in critical care. Advancing precision in patient monitoring refers to enhancing the accuracy, reliability, and real-time responsiveness of medical monitoring systems to ensure more precise tracking of patients' vital signs and clinical conditions. For instance, in July 2025, Shenzhen Antmed Co. Ltd., a China-based medical device manufacturer, launched a dual-channel disposable pressure transducer for invasive blood pressure monitoring with integrated blood sampling functionality. The system allows healthcare professionals to monitor two pressure channels simultaneously while maintaining high measurement stability and minimizing the risk of cross-contamination. It is designed to enhance workflow efficiency in critical care settings by combining accurate pressure monitoring with simplified operation and improved clinical safety.

In September 2024, Becton, Dickinson and Company, a US-based medical technology company, acquired the Critical Care Product Group from Edwards Lifesciences Corporation for an undisclosed amount. Through this acquisition, Becton, Dickinson and Company aims to expand its advanced patient monitoring and smart connected care portfolio by strengthening its capabilities in hemodynamic monitoring, critical care technologies, and AI-enabled clinical decision support solutions, further enhancing its position in hospital and intensive care environments. Edwards Lifesciences Corporation is a US-based company that provides disposable pressure transducers, including its TruWave product line.

Major companies operating in the disposable pressure transducers market are Ace Medical Co. Ltd., Argon Medical Devices Inc., B. Braun SE, Baxter International Inc., CODAN Medizinische Geräte GmbH, Demax Medical Technology, DeRoyal Industries Inc., Edwards Lifesciences Corporation, Elcam Medical Group, Guangdong Baihe Medical Technology Co. Ltd., Hisern Medical, ICU Medical Inc., Lepu Medical Technology Beijing Co. Ltd., Medline Industries LP, Merit Medical Systems Inc., Philips Healthcare LLC, SCW Medicath Ltd., Shenzhen Antmed Co. Ltd., Shenzhen Pray-Med Technology Co. Ltd., Utah Medical Products Inc.

North America was the dominating region in the disposable pressure transducers market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the disposable pressure transducers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the disposable pressure transducers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

This product will be delivered within 3-5 business days.